Lexicon Pharmaceuticals
LXRX
#6208
Rang
€0.89 Md
Capitalisation boursière
2,01 €
Prix de l'action
-0.43%
Changement (1 jour)
109.44%
Changement (1 an)

Lexicon Pharmaceuticals (LXRX) - Dette totale

Dette totale au bilan au Mars 2026 : 50.73 Millions d'euros

Selon les derniers rapports financiers de Lexicon Pharmaceuticals , la dette totale de l'entreprise est de 50.73 Millions d'euros. La dette totale d'une entreprise est la somme de toutes les dettes courantes et non courantes.

Lexicon Pharmaceuticals - Dette totale au bilan (de 2000 à 2026)

Dette totale par année

Année Dette totale Changement
2025-12-31€53.47 M-48.66%
2024-12-31€0.10 Md8.57%
2023-12-31€95.94 M86.13%
2022-12-31€51.54 M2461.56%
2021-12-31€2.01 M-80.68%
2020-12-31€10.41 M-95.25%
2019-12-31€0.21 Md2.43%
2018-12-31€0.21 Md4.6%
2017-12-31€0.20 Md112.29%
2016-12-31€96.44 M2.45%
2015-12-31€94.14 M6.34%
2014-12-31€88.52 M458.84%
2013-12-31€15.84 M-10.65%
2012-12-31€17.72 M-7.51%
2011-12-31€19.16 M-10.48%
2010-12-31€21.41 M-54.18%
2009-12-31€46.73 M114.29%
2008-12-31€21.81 M1.51%
2007-12-31€21.48 M-11.92%
2006-12-31€24.39 M-21.77%
2005-12-31€31.18 M12.41%
2004-12-31€27.74 M-38.01%
2003-12-31€44.75 M1069.56%
2002-12-31€3.82 M
2000-12-31€3.02 M-36.38%
1999-12-31€4.74 M

Dette totale pour des entreprises similaires ou concurrentes

Entreprise Dette totale/th> Dette totale différencediff. Pays
Thermo Fisher Scientific
TMO
€37.94 Md 74,693.35%🇺🇸 USA
Illumina
ILMN
€2.23 Md 4,308.48%🇺🇸 USA
Regeneron Pharmaceuticals
REGN
€2.37 Md 4,589.55%🇺🇸 USA
Ultragenyx Pharmaceutical
RARE
€31.64 M-37.62%🇺🇸 USA
Ligand Pharmaceuticals
LGND
€0.39 Md 683.23%🇺🇸 USA
Esperion Therapeutics
ESPR
€0.22 Md 337.78%🇺🇸 USA
Aerie Pharmaceuticals
AERI
€0.29 Md 483.96%🇺🇸 USA
BioMarin Pharmaceutical
BMRN
€1.26 Md 2,394.67%🇺🇸 USA
Eterna Therapeutics
ERNA
€0.34 M-99.33%🇺🇸 USA